Open Beta
TREN
MetriLume
TREN

US marketsAUPH

SEC-sourced researchBeta

AUPH

Aurinia Pharmaceuticals Inc.

Company comparison ↗

Data passport

CIK
0001600620
Exchange
Nasdaq
Business activity
Pharmaceutical Preparations · SIC 2834
Financial inputs
6/6
Filing date
Sep 11, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 175,513,000.0000 USD; December 2024: 235,133,000.0000 USD; December 2025: 283,055,000.0000 USD283.1M USD0 USD0December 2023December 2024December 2025
AUPH · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023175,513,000.0000Feb 26, 2026
December 2024235,133,000.0000Feb 26, 2026
December 2025283,055,000.0000Feb 26, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025283,055,000.0000287,202,000.0000135,658,000.0000751,587,000.0000170,256,000.0000Feb 26, 2026
December 2024235,133,000.00005,752,000.000044,388,000.0000550,645,000.0000173,167,000.0000Feb 26, 2026
December 2023175,513,000.0000-78,020,000.0000-33,461,000.0000——Feb 26, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

89/100
Profitability100
Growth70
Balance sheet77
Cash generation100
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$283.06MJan 1, 2025 – Dec 31, 2025Feb 26, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$235.13MJan 1, 2024 – Dec 31, 2024Feb 26, 202610-K
Net incomeNetIncomeLoss$287.2MJan 1, 2025 – Dec 31, 2025Feb 26, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$135.66MJan 1, 2025 – Dec 31, 2025Feb 26, 202610-K
Total assetsAssets$751.59MDec 31, 2025Feb 26, 202610-K
Total liabilitiesLiabilities$170.26MDec 31, 2025Feb 26, 202610-K

New filings

Explore methodology ↗